← Open Payments lookup

MORGAN GALLIART: Open Payments

NPI 1427533967 · RUSSELL, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$391 in 23 payments from 10 companies in 2025. Trend: 2023 $359 · 2024 $362 · 2025 $391

Food & beverage: $391
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation3$63
AstraZeneca Pharmaceuticals LP4$60
Amgen Inc.3$50
Insulet Corporation2$49
Sumitomo Pharma America, Inc.2$47
ABBVIE INC.3$47
Electromed, Inc.3$42
E.R. Squibb & Sons, L.L.C.1$17
Lilly USA, LLC1$14
Phathom Pharmaceuticals, Inc.1$2

Products named: LEQVIO, EVENITY, Omnipod, GEMTESA, FARXIGA, SMARTVEST, ELIQUIS, UBRELVY.

Industry payments across KS — which companies pay providers there.